MPM BIOVENTURES III QP LPother: Former 10% Ownerother: Former 10% Owner
Common Stock
25,000
N/A
N/A
Sale
EVNIN LUKEother: Former 10% Ownerother: Former 10% Owner
Common Stock
25,000
N/A
N/A
Sale
EVNIN LUKEother: Former 10% Ownerother: Former 10% Owner
Common Stock
400
N/A
N/A
Sale
HENNER DENNISdirectordirector
Common Stock
400
N/A
N/A
Sale
SIMON NICHOLAS J IIIdirectordirector
Common Stock
400
N/A
N/A
Sale
MPM BIOVENTURES III QP LPother: Former 10% Ownerother: Former 10% Owner
Common Stock
400
N/A
N/A
Sale
HENNER DENNISdirectordirector
Common Stock
315,902
N/A
N/A
Sale
EVNIN LUKEother: Former 10% Ownerother: Former 10% Owner
Common Stock
315,902
N/A
N/A
Sale
SIMON NICHOLAS J IIIdirectordirector
Common Stock
315,902
N/A
N/A
Sale
MPM BIOVENTURES III QP LPother: Former 10% Ownerother: Former 10% Owner
Common Stock
315,902
N/A
N/A
Sale
ALTA PARTNERS II INCother: X-ref Alta Partners II 5/20/04other: X-ref Alta Partners II 5..
Common Stock
60,300
N/A
N/A
Sale
DELEAGE JEANdirectordirector
Common Stock
60,300
N/A
N/A
Sale
DELEAGE JEANdirectordirector
Common Stock
9,700
N/A
N/A
Sale
ALTA PARTNERS II INCother: X-ref Alta Partners II 5/20/04other: X-ref Alta Partners II 5..
Common Stock
9,700
N/A
N/A
Sale
FRAZIER ALAN Ddirectordirector
COMMON STOCK
2,524
N/A
N/A
Sale
ALTA PARTNERS II INCother: X-ref Alta Partners II 5/20/04other: X-ref Alta Partners II 5..
Common Stock
1,200
N/A
N/A
Sale
DELEAGE JEANdirectordirector
Common Stock
1,200
N/A
N/A
Sale
DELEAGE JEANdirectordirector
Common Stock
7,487
N/A
N/A
Sale
ALTA PARTNERS II INCother: X-ref Alta Partners II 5/20/04other: X-ref Alta Partners II 5..
Common Stock
7,487
N/A
N/A
Sale
HENNER DENNISdirectordirector
Common Stock
17,334
N/A
N/A
Sale
SIMON NICHOLAS J IIIdirectordirector
Common Stock
17,334
N/A
N/A
Sale
MPM BIOVENTURES III QP LPother: Former 10% Ownerother: Former 10% Owner
Common Stock
17,334
N/A
N/A
Option
FRAZIER ALAN Ddirectordirector
Common Stock
520,832
N/A
N/A
Option
FRAZIER ALAN Ddirectordirector
Common Stock Purchase Warrant
260,416
N/A
N/A
Sale
SIMON NICHOLAS J IIIdirectordirector
Common Stock
172,373
N/A
N/A
Sale
MPM BIOEQUITIES MASTER FUND LP10 percent owner10 percent owner
Common Stock
172,373
N/A
N/A
Sale
FRAZIER ALAN Ddirectordirector
Common Stock
153,453
N/A
N/A
Sale
HENNER DENNISdirectordirector
Common Stock
172,373
N/A
N/A
Sale
FRAZIER HEALTHCARE IV LP10 percent owner10 percent owner
Common Stock
78,436
N/A
N/A
Sale
EVNIN LUKEother: Former 10% Ownerother: Former 10% Owner
Common Stock
17,334
N/A
N/A
Sale
DELEAGE JEANdirectordirector
Common Stock
186,160
N/A
N/A
Sale
MPM BIOVENTURES III QP LPother: Former 10% Ownerother: Former 10% Owner
Common Stock
172,373
N/A
N/A
Sale
ALTA PARTNERS II INCother: X-ref Alta Partners II 5/20/04other: X-ref Alta Partners II 5..
Common Stock
186,160
N/A
N/A
Purchase
COOPER ROBIN D Gofficer: Sr. V.P. Pharmaceutical Scs.officer: Sr. V.P. Pharmaceutica..
Common Stock
100
N/A
N/A
Showing 200 to 237 of 237 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.